US Stem Cell (USRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Sales | 5,521 | 3,083 | 2,191 | 2,056 | 96 |
| Cost of Goods | 1,885 | 972 | 973 | 845 | 31 |
| Gross Profit | 3,635 | 2,111 | 1,218 | 1,211 | 65 |
| Operating Expenses | 5,325 | 4,243 | 4,797 | 5,585 | 2,928 |
| Operating Income | -805 | -1,160 | -2,606 | -3,530 | -2,832 |
| Interest Expense | 642 | 1,186 | 1,723 | 1,640 | 1,438 |
| Other Income | -2,035 | 275 | 2,687 | 2,916 | 1,126 |
| Pre-tax Income | -3,482 | -2,070 | -1,642 | -2,254 | -3,143 |
| Net Income Continuous | -3,482 | -2,070 | -1,642 | -2,254 | -3,143 |
| Net Income | $-3,482 | $-2,070 | $-1,642 | $-2,254 | $-3,143 |
| EPS Basic Total Ops | -0.01 | -0.09 | -1.80 | -4.61 | -12.00 |
| EPS Basic Continuous Ops | -0.01 | -0.09 | -1.80 | -4.61 | -12.48 |
| EPS Diluted Total Ops | -0.01 | -0.09 | -1.80 | -4.61 | -12.00 |
| EPS Diluted Continuous Ops | -0.01 | -0.09 | -1.80 | -4.61 | -12.48 |
| EBITDA(a) | $-500 | $-1,154 | $-2,600 | $-3,525 | $-2,830 |